90576672 - INNOVATE TO EXCEL

Information

• Trademark
• 90576672

• Source

• Serial Number

  90576672

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations

• Filing Date

  March 12, 2021
  3 years ago

• Transaction Date

  February 13, 2023
  a year ago

• Status Date

  February 13, 2023
  a year ago

• Published for Opposition Date

  November 16, 2021
  2 years ago

• Location Date

  January 11, 2022
  2 years ago

• Status Code

  606

• Current Location

  INTENT TO USE SECTION

  Employee Name

  LAPTER, ALAIN J

• Attorney Name

  Paulo A. de Almeida

  Law Office Assigned Location Code

  L50

• Owners

  • Mabspace Biosciences (Suzhou) Co., Limited

Case File Statements

• DM0000: The mark consists of stylized words INNOVATE TO EXCEL.
• GS0051: Biochemical medicines for the treatment of cancer, musculoskeletal, genitourinary, oncological, ophthalmic, gastrointestinal, and immune system related diseases and disorders; Dietary supplements in the form of liquid; Blood for medical purposes; Pharmaceutical preparations for the treatment of cancer, musculoskeletal, genitourinary, oncological, ophthalmic, gastrointestinal, and immune system related diseases and disorders; Biological preparations for medical purposes for the treatment of cancer, musculoskeletal, genitourinary, oncological, ophthalmic, gastrointestinal, and immune system related diseases and disorders; Biological tissue cultures for medical purposes; Drugs for medical purposes for the treatment of cancer, musculoskeletal, genitourinary, oncological, ophthalmic, gastrointestinal, and immune system related diseases and disorders; Diagnostic preparations for medical purposes; Injectable pharmaceuticals for the treatment of cancer, musculoskeletal, genitourinary, oncological, ophthalmic, gastrointestinal, and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of cancer, musculoskeletal, genitourinary, oncological, ophthalmic, gastrointestinal, and immune system related diseases and disorders; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer

Case File Event Statements

• 2/13/2023 - a year ago

  19 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6

• 2/13/2023 - a year ago

  18 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6

• 3/26/2022 - 2 years ago

  17 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 3/24/2022 - 2 years ago

  16 - SOU EXTENSION 1 GRANTED Type: EX1G

• 3/24/2022 - 2 years ago

  15 - SOU EXTENSION 1 FILED Type: EXT1

• 3/24/2022 - 2 years ago

  14 - TEAS EXTENSION RECEIVED Type: EEXT

• 2/4/2022 - 2 years ago

  13 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN

• 1/11/2022 - 2 years ago

  12 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 11/16/2021 - 2 years ago

  11 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 11/16/2021 - 2 years ago

  10 - PUBLISHED FOR OPPOSITION Type: PUBO

• 10/27/2021 - 2 years ago

  9 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 10/11/2021 - 2 years ago

  8 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 10/11/2021 - 2 years ago

  7 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 10/11/2021 - 2 years ago

  6 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 10/11/2021 - 2 years ago

  5 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 10/11/2021 - 2 years ago

  4 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 10/8/2021 - 2 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 6/14/2021 - 3 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 3/16/2021 - 3 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP